Blood-Based Biomarker Testing for Alzheimer Disease in US Clinical Practice
JAMA · 18.11.2026
DOI: 10.1001/jama.2026.23534 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, online erschienen am 18.11.2026. Verfasst von Mengyuan Fu und 4 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
This cohort study examines the rates of blood-based biomarker testing for Alzheimer disease in US clinical practice, exploring patient characteristics, ordering clinician specialty, and diagnostic and treatment events.
Zitieren
APA
Fu, M., Andersen, M., Ramachandran, R., Berg, K. M., & Ross, J. S. (2026). Blood-Based Biomarker Testing for Alzheimer Disease in US Clinical Practice. JAMA. https://doi.org/10.1001/jama.2026.23534
Vancouver
Fu M, Andersen M, Ramachandran R, Berg KM, Ross JS. Blood-Based Biomarker Testing for Alzheimer Disease in US Clinical Practice. JAMA. 2026. doi:10.1001/jama.2026.23534
BibTeX
@article{Fu2026,
author = {Fu, Mengyuan and Andersen, Matthew and Ramachandran, Reshma and Berg, Karina M. and Ross, Joseph S.},
title = {Blood-Based Biomarker Testing for Alzheimer Disease in US Clinical Practice},
journal = {JAMA},
year = {2026},
doi = {10.1001/jama.2026.23534}
}
EUVIMED